Mehrdad Arjomandi

Mehrdad Arjomandi

Auto-generated profile, based on publicly available information

Mehrdad Arjomandi

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2018 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
MGMehrnaz Ghasemiesfe
Mehrnaz Ghasemiesfe
DRDivya Ravi
Divya Ravi
MVMarzieh Vali
Marzieh Vali
DKDeborah Korenstein
Deborah Korenstein
MAMehrdad Arjomandi
Mehrdad Arjomandi
SKSalomeh Keyhani
Salomeh Keyhani
The health effects of smoking marijuana are not well-understood. To examine the association between marijuana use and respiratory symptoms, pulmonary function, and obstructive lung disease among adolescents and adults. PubMed, Embase, PsycINFO, MEDLINE, and the Cochrane Library from 1 January 1973 to 30 April 2018. Observational and interventional studies published in English that reported pulmonary outcomes of adolescents and adults who used marijuana. Four reviewers independently extracted study characteristics and assessed risk of bias. Three reviewers assessed strength of evidence. Studies of similar design with low or moderate risk of bias and sufficient data were pooled. Twenty-two studies were included. A pooled analysis of 2 prospective studies showed that marijuana use was associated with an increased risk for cough (risk ratio [RR], 2.04 [95% CI, 1.02 to 4.06]) and sputum production (RR, 3.84 [CI, 1.62 to 9.07]). Pooled analysis of cross-sectional studies (1 low and 3 moderate risk of bias) showed that marijuana use was associated with cough (RR, 4.37 [CI, 1.71 to 11.19]), sputum production (RR, 3.40 [CI, 1.99 to 5.79]), wheezing (RR, 2.83 [CI, 1.89 to 4.23]), and dyspnea (RR, 1.56 [CI, 1.33 to 1.83]). Data on pulmonary function and obstructive lung disease were insufficient. Few studies were at low risk of bias, marijuana exposure was limited in the population studied, cohorts were young overall, assessment of marijuana exposure was not uniform, and study designs varied. Low-strength evidence suggests that smoking marijuana is associated with cough, sputum production, and wheezing. Evidence on the association between marijuana use and obstructive lung disease and pulmonary function is insufficient. None. (PROSPERO: CRD42017059224)

1 December 2007 in Environmental Health Perspectives
Verified
Journal Article
Open access
CCConnie Chen
Connie Chen
MAMehrdad Arjomandi
Mehrdad Arjomandi
JBJohn Balmes
John Balmes
ITIra Tager
Ira Tager
NHNina Holland
Nina Holland
BackgroundThere is growing evidence for the role of oxidative damage in chronic diseases. Although ozone (O3) is an oxidant pollutant to which many people are exposed, few studies have examined whether O3 induces oxidative stress in humans.ObjectivesThis study was designed to assess the effect of short-and long-term O3 exposures on biomarkers of oxidative stress in healthy individuals.MethodsBiomarkers of lipid peroxidation, 8-isoprostane (8-iso-PGF), and antioxidant capacity ferric reducing ability of plasma (FRAP) were analyzed in two groups of healthy college students with broad ranges of ambient O3 exposure during their lifetimes and previous summer recess either in Los Angeles (LA, n = 59) or the San Francisco Bay Area (SF, n = 61).ResultsEstimated 2-week, 1-month, and lifetime O3 exposures were significantly correlated with elevated 8-iso-PGF. Elevated summertime exposures resulted in the LA group having higher levels of 8-iso-PGF than the SF group (p = 0.02). Within each location, males and females...

15 June 2015 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
MAMehrdad Arjomandi
Mehrdad Arjomandi
HWHofer Wong
Hofer Wong
ADAneesh Donde
Aneesh Donde
JFJessica Frelinger
Jessica Frelinger
SDSarah Dalton
Sarah Dalton
JBJohn R. Balmes
John R. Balmes
Epidemiological evidence suggests that exposure to ozone increases cardiovascular morbidity. However, the specific biological mechanisms mediating ozone-associated cardiovascular effects are unknown. To determine whether short-term exposure to ambient levels of ozone causes changes in biomarkers of cardiovascular disease including heart rate variability (HRV), systemic inflammation, and coagulability, 26 subjects were exposed to 0, 100, and 200 ppb ozone in random order for 4 h with intermittent exercise. HRV was measured and blood samples were obtained immediately before (0 h), immediately after (4 h), and 20 h after (24 h) each exposure. Bronchoscopy with bronchoalveolar lavage (BAL) was performed 20 h after exposure. Regression modeling was used to examine dose-response trends between the endpoints and ozone exposure. Inhalation of ozone induced dose-dependent adverse changes in the frequency domains of HRV across exposures consistent with increased sympathetic tone [increase of (parameter estimate ± SE) 0.4 ± 0.2 and 0.3 ± 0.1 in low- to high-frequency domain HRV ratio per 100 ppb increase in ozone at 4 h and 24 h, respectively (P = 0.02 and P = 0.01)] and a dose-dependent increase in serum C-reactive protein (CRP) across exposures at 24 h [increase of 0.61 ± 0.24 mg/l in CRP per 100 ppb increase in ozone (P = 0.01)]. Changes in HRV and CRP did not correlate with ozone-induced local lung inflammatory responses (BAL granulocytes, IL-6, or IL-8), but changes in HRV and CRP were associated with each other after adjustment for age and ozone level. Inhalation of ozone causes adverse systemic inflammatory and cardiac autonomic effects that may contribute to the cardiovascular mortality associated with short-term exposure.

15 May 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
MAMehrdad Arjomandi
Mehrdad Arjomandi
John BalmesJohn Balmes
John Balmes
MFMark W. Frampton
Mark W. Frampton
PBPhilip Bromberg
Philip Bromberg
DRDavid Q. Rich
David Q. Rich
MHMilan J. Hazucha
Milan J. Hazucha
Rationale: Acute respiratory effects of low-level ozone exposure are not well defined in older adults. Objective: The Multicenter Ozone Study in oldEr Subjects (MOSES), although primarily focused on acute cardiovascular effects, provided an opportunity to assess respiratory responses to low concentrations of ozone in older healthy adults. Methods: We performed a randomized crossover, controlled exposure study of 87 healthy adults (59.9±4.5 years old; 60% female) to 0, 70, and 120 ppb ozone for 3 hours with intermittent exercise. Outcome measures were spirometry, sputum markers of airway inflammation, and plasma club cell protein-16 (CC16), a marker of airway epithelial injury. The effects of ozone exposure on these outcomes were evaluated with mixed effect linear models. A p-value <0.01 was chosen a priori to define statistical significance. Main Results: The mean (95% CI) FEV1 and FVC increased from pre-exposure values by 2.7% (2.0, 3.4) and 2.1% (1.3, 2.9), respectively, 15 min post-exposure to filtered air (0 ppb). Exposure to ozone reduced these increases in a concentration-dependent manner. After 120 ppb exposure, FEV1 and FVC decreased by 1.7% (1.1, 2.3) and 0.8% (0.3, 1.3), respectively. A similar concentration-dependent pattern was still discernible 22 h post-exposure. At 4 h post-exposure, plasma CC16 increased from pre-exposure levels in an ozone-concentration-dependent manner. Sputum neutrophils obtained 22 h post-exposure showed a marginally significant increase in a concentration-dependent manner (p=0.012), but pro-inflammatory cytokines (IL-6, IL-8, TNFα) were not significantly affected. Conclusions: Exposure to ozone at near ambient levels induced lung function effects, airway injury, and airway inflammation in older healthy adults. Clinical trial registration available at www.clinicaltrials.gov, ID NCT01487005

1 November 1996 in JACC
Verified
Journal Article
Open access
BWBing-Yin Wang
Bing-Yin Wang
RCRobert C. Candipan
Robert C. Candipan
MAMehrdad Arjomandi
Mehrdad Arjomandi
PHPaul T.C. Hsiun
Paul T.C. Hsiun
PTPhilip S. Tsao
Philip S. Tsao
John Patrick CookeJohn Patrick Cooke
John Patrick Cooke
This study sought to determine whether the alterations in vascular function and structure after balloon injury in hypercholesterolemic rabbits could be inhibited by dietary arginine. Administration of arginine (the nitric oxide [NO] precursor) restores vascular NO activity in hypercholesterolemic animals. We and other investigators have shown that enhancement of vascular NO activity can inhibit myointimal hyperplasia after vascular injury in normocholesterolemic animals. Twenty-eight New Zealand White rabbits received either normal rabbit chow, 0.5% cholesterol diet or 0.5% cholesterol diet plus L-arginine hydrochloride (2.25% wt/vol) in the drinking water. After 6 weeks of dietary intervention, the left iliac artery of each animal was subjected to a balloon injury. Four weeks later, the iliac arteries were harvested for vascular reactivity studies and immunohistochemical analysis. Vascular injury induced intimal thickening that was largely composed of vascular smooth muscle cells and extracellular matrix. In the setting of hypercholesterolemia, vascular injury induced an exuberant myointimal lesion that was augmented by the accumulation of lipid-laden macrophages. Dietary arginine reduced intimal thickening in the injured vessels of hypercholes-terolemic animals and substantially inhibited the accumulation of macrophages in the lesion (from 28% to 5% of the lesion area, p < 0.001). We report that lesions induced by vascular injury in hypercholesterolemic animals are markedly reduced by oral administration of arginine. Moreover, we find that the nature of the lesion is altered, with a striking reduction in the percentage of macrophages comprising the lesion.

28 September 2018 in PeerJ
Verified
Journal Article
Open access
PDF file
SLSusan M. Lee
Susan M. Lee
RTRachel Tenney
Rachel Tenney
AWArthur W. Wallace
Arthur W. Wallace
MAMehrdad Arjomandi
Mehrdad Arjomandi
Introduction: Cigarette smoking by surgical patients is associated with increased complications. E-cigarettes have emerged as a potential smoking cessation tool. We sought to determine the feasibility and acceptability of e-cigarettes, compared to nicotine patch, for perioperative smoking cessation in veterans. Methods: Preoperative patients were randomized to either the nicotine patch group (n = 10) or the e-cigarette group (n = 20). Both groups were given a free 6-week supply in a tapering dose. All patients received brief counseling, a brochure on perioperative smoking cessation, and referral to the California Smokers’ Helpline. The primary outcome was rate of smoking cessation on day of surgery confirmed by exhaled carbon monoxide. Secondary outcomes included smoking habits, pulmonary function, adverse events, and satisfaction with the products on day of surgery and at 8-weeks follow-up. Results: Biochemically verified smoking cessation on day of surgery was similar in both groups. Change in forced expiratory volume in one second (FEV1) was 592 ml greater in the e-cigarette group (95% CI [153–1,031] ml, p = 0.01) and change in forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC ratio) was 40.1% greater in the e-cigarette group (95% CI [18.2%–78.4%], p = 0.04). Satisfaction with the product was similar in both groups. Discussion: E-cigarettes are a feasible tool for perioperative smoking cessation in veterans with quit rates comparable to nicotine replacement patch. Spirometry appears to be improved 8-weeks after initiating e-cigarettes compared to nicotine patch, possibly due to worse baseline spirometry and more smoking reduction in the e-cigarette group. An adequately powered study is recommended to determine if these results can be duplicated.